Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.782 INR | +0,28% | +1,84% | -7,41% |
Omzet 2024 * | 56,49 mld. 678 mln. 635 mln. | Omzet 2025 * | 63,2 mld. 759 mln. 710 mln. | Marktkapitalisatie | 293 mld. 3,51 mld. 3,29 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 8,48 mld. 102 mln. 95,31 mln. | Nettowinst (verlies) 2025 * | 11,02 mld. 132 mln. 124 mln. | EV/omzet 2024 * | 4,69 x |
Nettoliquiditeiten 2024 * | 27,5 mld. 330 mln. 309 mln. | Nettoliquiditeiten 2025 * | 31,55 mld. 379 mln. 355 mln. | EV/omzet 2025 * | 4,13 x |
K/w-verhouding 2024 * |
34,4
x | K/w-verhouding 2025 * |
26,5
x | Werknemers | 4.585 |
Dividendrendement 2024 * |
0,1% | Dividendrendement 2025 * |
0,19% | Vrij verhandelbaar | 38,38% |
Recentste transcriptie over Gland Pharma Limited
1 dag | +0,28% | ||
1 week | +1,84% | ||
Lopende maand | -3,43% | ||
1 maand | -0,53% | ||
3 maanden | -5,48% | ||
6 maanden | +17,28% | ||
Lopend jaar | -7,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 01-01-00 |
Director of Finance/CFO | - | 30-09-19 | |
C. S. Venkatesan
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10-03-22 |
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 01-01-00 |
Yiu Kwan Lau
CHM | Chairman | 69 | 10-06-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 1.782 | +0,28% | 76 362 |
22-04-24 | 1.777 | +0,75% | 86 990 |
19-04-24 | 1.764 | -0,05% | 96 212 |
18-04-24 | 1.764 | +0,84% | 346 803 |
16-04-24 | 1.750 | -0,15% | 187 181 |
uitgestelde koers NSE India S.E., 23 april 2024 om 13:51 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,41% | 3,51 mld. | |
+25,46% | 659 mld. | |
+26,92% | 557 mld. | |
-4,86% | 359 mld. | |
+16,44% | 322 mld. | |
+8,34% | 297 mld. | |
+6,23% | 215 mld. | |
+7,06% | 210 mld. | |
-6,05% | 200 mld. | |
-8,79% | 149 mld. |